Quick Takeaways
- TXG - 10x Genomics, Inc. has 14 insiders with reported activity on this page.
- Net insider value flow over the last year: -$2,642,135.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 14 Insiders of 10x Genomics, Inc.
- Symbol
- TXG on Nasdaq
- Location
- Pleasanton, CA
What Changed
- Buy value: ; sell value: $2,642,134.
- Net share flow: -158,610.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$2,642,135.
Buys
$0
Shares: 0
Insiders: 0
Sells
$2,642,135
Shares: 158,610
Insiders: 4
Net
-$2,642,135
Shares: -158,610
Insiders: -4
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 65,157 | $0 | $1,294,013 | -$1,294,013 |
| 3-6 | 0 | 33,432 | $0 | $635,151 | -$635,151 |
| 6-9 | 0 | 39,149 | $0 | $539,747 | -$539,747 |
| 9-12 | 0 | 20,872 | $0 | $173,223 | -$173,223 |
10x Genomics, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Bryan E. Roberts | Director | $195,830,277 | Mixed | 14 Jun 2023 | ||
| Serge Saxonov | Chief Executive Officer, Director | $87,144,992 | -$1,293,291 | -1.5% | Mixed | 23 Mar 2026 |
| Benjamin J. Hindson | Title: President and Chief Scientific Officer, Director | $10,826,582 | -$468,072 | -4.1% | Mixed | 26 Feb 2026 |
| Adam Taich | Chief Financial Officer | $8,326,515 | -$733,664 | -8.1% | Mixed | 26 Feb 2026 |
| Bradford Crutchfield | former officer | $4,438,548 | Mixed | 29 Jul 2022 | ||
| Mathai Mammen | Director | $4,380,943 | Mixed | 11 Jun 2024 | ||
| James Wilbur | Chief Commercial Officer | $3,804,287 | Mixed | 22 Nov 2023 | ||
| John R. Stuelpnagel | Director | $3,412,670 | Mixed | 03 Jun 2025 | ||
| Justin J. McAnear | Former Chief Financial Officer | $3,227,199 | Filing P/S | 22 Aug 2024 | ||
| Alan Mateo | Director | $731,185 | Mixed | 03 Jun 2025 | ||
| Sridhar Kosaraju | Director | $564,171 | Mixed | 03 Jun 2025 | ||
| Sarah A. Teichmann | Director | $519,799 | -$147,108 | -22% | Filing P/S | 25 Feb 2026 |
| Shehnaaz Suliman | Director | $271,565 | Mixed | 03 Jun 2025 | ||
| Kimberly J. Popovits | Director | $271,565 | Mixed | 03 Jun 2025 |
Top shareholders of 10x Genomics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13D/G
13F
|
Company |
16%
|
18,543,562
|
$355,109,205 | +$111,975,948 | 27 Feb 2026 | |
| VANGUARD GROUP INC |
13F
13D/G
|
Company · The Vanguard Group |
12%
from 13D/G
|
13,017,914
|
$212,322,177 | — | 31 Dec 2025 | |
| ARK Investment Management LLC |
13F
13D/G
|
Company |
10%
from 13D/G
|
12,667,369
|
$206,604,788 | — | 31 Dec 2025 | |
| Bryan E. Roberts |
3/4/5
|
Director |
—
mixed-class rows
|
4,294,791
mixed-class rows
|
$195,830,277 | — | 14 Jun 2023 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
7.6%
from 13D/G
|
10,014,462
|
$163,335,875 | — | 31 Dec 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
13D/G
|
Company |
4.7%
from 13D/G
|
5,492,189
|
$89,577,603 | — | 31 Dec 2025 | |
| Amova Asset Management Americas, Inc. |
13F
13D/G
|
Company |
4.7%
from 13D/G
|
5,486,153
|
$89,424,294 | — | 31 Dec 2025 | |
| Serge Saxonov |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
4,268,444
mixed-class rows
|
$87,144,992 | -$1,293,291 | 23 Mar 2026 | |
| Quantinno Capital Management LP |
13F
|
Company |
3.9%
|
4,667,203
|
$76,122,081 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
2.7%
|
3,196,893
|
$52,141,338 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.6%
|
3,087,267
|
$50,353,325 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
2,789,784
|
$45,509,358 | — | 31 Dec 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
2.2%
|
2,639,999
|
$43,058,384 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.2%
|
2,579,051
|
$41,857,998 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
2,512,519
|
$40,979,185 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13D/G
13F
|
Company |
2.7%
|
3,060,859
|
$36,913,960 | -$29,821,474 | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.5%
|
1,837,520
|
$29,969,951 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.3%
|
1,550,539
|
$25,289,291 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.3%
|
1,517,581
|
$24,751,651 | — | 31 Dec 2025 | |
| Capital World Investors |
13F
|
Company |
1.2%
|
1,452,300
|
$23,687,013 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.2%
|
1,448,765
|
$23,629,358 | — | 31 Dec 2025 | |
| Casdin Capital, LLC |
13F
|
Company |
1.2%
|
1,400,000
|
$22,834,000 | — | 31 Dec 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
1.1%
|
1,279,503
|
$20,869,000 | — | 31 Dec 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.1%
|
1,264,900
|
$20,630,519 | — | 31 Dec 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
1%
|
1,228,703
|
$20,040,146 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.97%
|
1,155,691
|
$18,849,320 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.93%
|
1,106,322
|
$18,044,112 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.84%
|
993,380
|
$16,202,029 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.78%
|
928,426
|
$15,142,629 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.72%
|
861,000
|
$14,042,910 | — | 31 Dec 2025 | |
| Freshford Capital Management, LLC |
13F
|
Company |
0.7%
|
833,302
|
$13,591,156 | — | 31 Dec 2025 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.64%
|
760,096
|
$12,397,162 | — | 31 Dec 2025 | |
| Trexquant Investment LP |
13F
|
Company |
0.63%
|
752,634
|
$12,275,461 | — | 31 Dec 2025 | |
| ARCH Venture Management, LLC |
13F
|
Company |
0.62%
|
737,539
|
$12,029,261 | — | 31 Dec 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.6%
|
709,579
|
$11,573,233 | — | 31 Dec 2025 | |
| Benjamin J. Hindson |
3/4/5
|
Title: President and Chief Scientific Officer, Director |
0.43%
|
513,595
|
$10,826,582 | -$468,072 | 26 Feb 2026 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.54%
|
644,908
|
$10,518,449 | — | 31 Dec 2025 | |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd |
13F
|
Company |
0.53%
|
632,079
|
$10,309,208 | — | 31 Dec 2025 | |
| CLOUGH CAPITAL PARTNERS L P |
13F
|
Company |
0.51%
|
610,374
|
$9,955,200 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.46%
|
545,826
|
$8,902,422 | — | 31 Dec 2025 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.45%
|
533,947
|
$8,708,677 | — | 31 Dec 2025 | |
| Adam Taich |
3/4/5
|
Chief Financial Officer |
0.33%
|
394,996
|
$8,326,515 | -$733,664 | 26 Feb 2026 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.41%
|
485,977
|
$7,926,285 | — | 31 Dec 2025 | |
| Sands Capital Alternatives, LLC |
13F
|
Company |
0.41%
|
481,770
|
$7,857,669 | — | 31 Dec 2025 | |
| Man Group plc |
13F
|
Company |
0.33%
|
393,064
|
$6,410,874 | — | 31 Dec 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.33%
|
390,280
|
$6,365,000 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.32%
|
383,169
|
$6,249,486 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.3%
|
350,964
|
$5,724,231 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.29%
|
344,950
|
$5,626,135 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.28%
|
334,300
|
$5,452,433 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for 10x Genomics, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Serge Saxonov | TXG | Class A Common Stock | Sale | -0.42% | $97,612 | $19.52 | -5,000 | 1,172,273 | 24 Mar 2026 | Direct |
| Serge Saxonov | TXG | Class A Common Stock | Sale | -0.84% | $191,297 | $19.13 | -10,000 | 1,177,273 | 23 Mar 2026 | Direct |
| Serge Saxonov | TXG | Class A Common Stock | Gift | -0.23% | -2,750 | 1,200,917 | 03 Mar 2026 | Direct | ||
| Serge Saxonov | TXG | Class A Common Stock | Sale | -1.32% | $367,097 | $22.73 | -16,152 | 1,203,667 | 02 Mar 2026 | Direct |
| Serge Saxonov | TXG | Class A Common Stock | Award | 14.9% | 157,895 | 1,219,819 | 26 Feb 2026 | Direct | ||
| Benjamin J. Hindson | TXG | Class A Common Stock | Award | 20.9% | 88,816 | 513,595 | 26 Feb 2026 | Direct | ||
| Adam Taich | TXG | Class A Common Stock | Award | 37% | 106,579 | 394,996 | 26 Feb 2026 | Direct | ||
| Sarah A. Teichmann | TXG | Class A Common Stock | Sale | -22.1% | $147,108 | $19.41 | -7,579 | 26,780 | 25 Feb 2026 | Direct |
| Serge Saxonov | TXG | Class A Common Stock | Sale | -0.9% | $178,928 | $18.58 | -9,632 | 1,061,924 | 23 Feb 2026 | Direct |
| Adam Taich | TXG | Class A Common Stock | Sale | -3.02% | $166,593 | $18.58 | -8,968 | 288,417 | 23 Feb 2026 | Direct |
| Benjamin J. Hindson | TXG | Class A Common Stock | Sale | -1.81% | $145,379 | $18.58 | -7,826 | 424,779 | 23 Feb 2026 | Direct |
| Serge Saxonov | TXG | Class A Common Stock | Options Exercise | 4.89% | 50,000 | 1,071,556 | 05 Jan 2026 | Direct | ||
| Serge Saxonov | TXG | Stock Option (right to buy) | Options Exercise | -100% | -50,000 | 0 | 05 Jan 2026 | Direct | ||
| Adam Taich | TXG | Class A Common Stock | Sale | -3.84% | $225,852 | $19.00 | -11,888 | 297,385 | 24 Nov 2025 | Direct |
| Benjamin J. Hindson | TXG | Class A Common Stock | Sale | -1.88% | $157,363 | $19.00 | -8,283 | 432,605 | 24 Nov 2025 | Direct |
| Serge Saxonov | TXG | Class A Common Stock | Sale | -1.28% | $251,936 | $19.00 | -13,261 | 1,021,556 | 24 Nov 2025 | Direct |
| Serge Saxonov | TXG | Class A Common Stock | Gift | -0.09% | -900 | 1,034,817 | 12 Sep 2025 | Direct | ||
| Serge Saxonov | TXG | Class A Common Stock | Sale | -0.98% | $128,881 | $13.79 | -9,348 | 945,892 | 22 Aug 2025 | Direct |
| Adam Taich | TXG | Class A Common Stock | Sale | -6.73% | $307,657 | $13.79 | -22,315 | 309,273 | 22 Aug 2025 | Direct |
| Benjamin J. Hindson | TXG | Class A Common Stock | Sale | -1.67% | $103,209 | $13.79 | -7,486 | 440,888 | 22 Aug 2025 | Direct |
| Serge Saxonov | TXG | Class A Common Stock | Gift | -0.1% | -1,000 | 955,240 | 09 Jun 2025 | Direct | ||
| Sarah A. Teichmann | TXG | Class A Common Stock | Award | 80.8% | 15,357 | 34,359 | 03 Jun 2025 | Direct | ||
| Shehnaaz Suliman | TXG | Class A Common Stock | Award | 115.8% | 15,357 | 28,616 | 03 Jun 2025 | Direct | ||
| John R. Stuelpnagel | TXG | Class A Common Stock | Award | 4.46% | 15,357 | 359,607 | 03 Jun 2025 | Direct | ||
| Kimberly J. Popovits | TXG | Class A Common Stock | Award | 115.8% | 15,357 | 28,616 | 03 Jun 2025 | Direct | ||
| Alan Mateo | TXG | Class A Common Stock | Award | 24.9% | 15,357 | 77,048 | 03 Jun 2025 | Direct | ||
| Sridhar Kosaraju | TXG | Class A Common Stock | Award | 37.4% | 15,357 | 56,449 | 03 Jun 2025 | Direct | ||
| Serge Saxonov | TXG | Class A Common Stock | Gift | -0.28% | -3,000 | 1,080,625 | 29 May 2025 | Direct | ||
| Serge Saxonov | TXG | Class A Common Stock | Sale | -0.85% | $77,540 | $8.30 | -9,343 | 1,083,625 | 22 May 2025 | Direct |
| Benjamin J. Hindson | TXG | Class A Common Stock | Sale | -1.64% | $62,120 | $8.30 | -7,485 | 448,374 | 22 May 2025 | Direct |
| Adam Taich | TXG | Class A Common Stock | Sale | -1.2% | $33,562 | $8.30 | -4,044 | 331,588 | 22 May 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.